Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Drug-sensitivity of resistant acute myeloid leukemia cell line to Doxorubicin is enhanced by Triptolide through down-regulation of HIF-1α and Nrf2

Bing Xu, MD, Feili Chen, M.D., Yuejian Liu, M.D., Shiyun Wang, M.D., Rongwei Li, MD, Huijuan Dong, MD

Blood (2013) 122 (21): 4921.

https://doi.org/10.1182/blood.V122.21.4921.4921

Published: 2013

Journal Articles

Low-dose Triptolide could enhance the Idarubicin-induced apoptosis in KG1α cells through down-regulation of MDR1 and NF-κb

Bing Xu, MD, Jiahong Tang, MD, Feili Chen, M.D., Yanyan Li, MD, Huijuan Dong, MD, Yuejian Liu, M.D., Shuyun Zhou, MD, PhD

Blood (2013) 122 (21): 4922.

https://doi.org/10.1182/blood.V122.21.4922.4922

Published: 2013

Journal Articles

Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2

Bing Xu, MD, Feili Chen, M.D., Yuejian Liu, M.D., Shiyun Wang, M.D., Rongwei Li, MD, Huijuan Dong, MD, Jie Zha, M.D.

Blood (2013) 122 (21): 4928.

https://doi.org/10.1182/blood.V122.21.4928.4928

Published: 2013

Journal Articles

Disulfiram, an clinically used anti-alcoholism drug has the potential to target acute myeloid leukemia cells in a copper-dependent manner in vivo

Bing Xu, MD, Rongwei Li, MD, Huijuan Dong, MD, Feili Chen, M.D., Yuejian Liu, M.D., Shiyun Wang, M.D., Shuyun Zhou, MD, PhD

Blood (2013) 122 (21): 5040.

https://doi.org/10.1182/blood.V122.21.5040.5040

Published: 2013

Journal Articles

Low-dose Triptolide in combination with Idarubicin could induce apoptosis in leukemia stem and progenitor cells via affecting the intrinsic and extrinsic factors

Bing Xu, MD, Yuejian Liu, M.D., Feili Chen, M.D., Rongwei Li, MD, Shiyun Wang, M.D., Huijuan Dong, MD, Weiguang Wang, M.D. PhD

Blood (2013) 122 (21): 5410.

https://doi.org/10.1182/blood.V122.21.5410.5410

Published: 2013

Journal Articles

Comparative Efficacy of Homoharringtonine Plus Cytarabine and Decitabine in Patients with MDS/AML

Yuejian Liu, M.D., Feili Chen, M.D., Xutao Guo, M.D., Pengcheng Shi, M.D., Jie Zha, M.D., Zhiping Fan, Fen Huang, M.D., Bing Xu, M.D. PhD

Blood (2012) 120 (21): 4340.

https://doi.org/10.1182/blood.V120.21.4340.4340

Published: 2012

NARROW

Drug-sensitivity of resistant acute myeloid leukemia cell line to Doxorubicin is enhanced by Triptolide through down-regulation of HIF-1α and Nrf2

Low-dose Triptolide could enhance the Idarubicin-induced apoptosis in KG1α cells through down-regulation of MDR1 and NF-κb

Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2

Disulfiram, an clinically used anti-alcoholism drug has the potential to target acute myeloid leukemia cells in a copper-dependent manner in vivo

Low-dose Triptolide in combination with Idarubicin could induce apoptosis in leukemia stem and progenitor cells via affecting the intrinsic and extrinsic factors

Comparative Efficacy of Homoharringtonine Plus Cytarabine and Decitabine in Patients with MDS/AML

Email alerts

ASH Publications

American Society of Hematology

Drug-sensitivity of resistant acute myeloid leukemia cell line to Doxorubicin is enhanced by Triptolide through down-regulation of HIF-1α and Nrf2

Low-dose Triptolide could enhance the Idarubicin-induced apoptosis in KG1α cells through down-regulation of MDR1 and NF-κb

Imatinib-induced apoptosis could be enhanced by Triptolide in Imatinib-resistant chronic myeloid leukemia cell line through down-regulation of HIF-1αand Nrf2

Disulfiram, an clinically used anti-alcoholism drug has the potential to target acute myeloid leukemia cells in a copper-dependent manner in vivo

Low-dose Triptolide in combination with Idarubicin could induce apoptosis in leukemia stem and progenitor cells via affecting the intrinsic and extrinsic factors

Comparative Efficacy of Homoharringtonine Plus Cytarabine and Decitabine in Patients with MDS/AML

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only